Machine Learning Researchers Leverage AI to Decode Alzheimer’s Disease and Uncover Promising Drug Targets AiT Analyst Aug 21, 2023 Alzheimer's disease is a critical neurological disorder that affects millions of people across the United States. It impacts the behavior, thinking,…
Healthcare Management Nurosene Partners With Brain Computer Interface Technology Ni2o To Pioneer Research For Alzheimer’s… AIT News Desk Nov 30, 2021 Ni2o will use Nurosene’s NetraAI technology to accelerate their research into neurodegenerative disease treatments. Nurosene Health Inc., a…
Life Sciences Qynapse (France) and True Positive Medical Devices (Canada) Are Partnering to Provide the Most… AIT News Desk Oct 13, 2020 Strategic partnership in brain imaging and AI QYNAPSE SAS, a French medical technology company, announces the acquisition of the Canadian company…